Physicians' Awareness on the Safety of Herbal Products


Gökkaya İ., Özceylan Ö. F., Çolak B., Renda G., Duman M., Duman E. N.

14th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 25 - 28 Haziran 2024, ss.351

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Ankara
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.351
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Introduction: The use of herbal products among the population is becoming more common in Turkiye. In accordance with this, it is noted that the number of adverse effects associated with the use of herbal products is increasing. Phytovigilance, or phytopharmacovigilance, is defined as the detection, evaluation, and prevention of adverse reactions and other potential problems associated with the use of herbal products (1,2). It is very important for physicians who are responsible for following the treatment of patients to identify and report the side effects of herbal products. This study aimed to determine, the awareness of physicians about the phytovigilance system and the factors affecting this awareness, for the first time in Turkiye.

Materials and Methods: The descriptive study was conducted at Karadeniz Technical University Farabi Hospital between November 1, 2023 and February 1, 2024, by using the face-to-face interview technique. It was a survey, including two main sections and 21 questions. The statistical analysis was performed with SPSS 23.0. The combined effects of all possible variables, which might be associated with phytovigilance awareness, were assessed by binary logistic regression analysis using the Backward LR elimination method. The p<0.05 indicates the significance level.

Results: Among 268 survey responses in the study, 56.7% of the participants were male, and 66.8% were working in internal medicine. The mean work experience was 6.6 ± 7.7 years. Among the participants, 45.5% had heard of the concept of phytovigilance. 69.8% of respondents did not know that adverse reactions related to the use of herbal products were reported in Türkiye. Among those who were aware of the feedback process, 70.4% did not know that hepatotoxicity and nephrotoxicity notification forms were filled out in the feedback. Only 27.2% of physicians knew that there was a phytovigilance contact point in the hospital where they worked. It was determined that the factors that enhance phytovigilance awareness were being a specialist physician [Odds ratio (OR) = 4.591; p = 0.001], knowing that adverse effects related to herbal products were reported feedback (OR = 2.678; p = 0.001), and questioning the use of herbal products while taking the medical history of patients (OR = 3.522; p = 0.012).

Conclusions: It was revealed that the knowledge of the physicians about the phytovigilance system in Turkiye was quite low. To improve awareness, information campaigns on the phytovigilance system should be organized in hospitals, and the process of ensuring the safety of herbal products should be integrated into the curricula of undergraduate medical faculty.